Lumit: A Homogeneous Bioluminescent Immunoassay for Detecting Diverse Analytes and Intracellular Protein Targets.

Antibody Bioluminescence Cytokine Homogeneous Immunoassay NanoBiT Phosphorylation SARS-CoV2

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2023
Historique:
entrez: 16 2 2023
pubmed: 17 2 2023
medline: 22 2 2023
Statut: ppublish

Résumé

Traditional immunoassays to detect secreted or intracellular proteins can be tedious, require multiple washing steps, and are not easily adaptable to a high-throughput screening (HTS) format. To overcome these limitations, we developed Lumit, a novel immunoassay approach that combines bioluminescent enzyme subunit complementation technology and immunodetection. This bioluminescent immunoassay does not require washes or liquid transfers and takes less than 2 h to complete in a homogeneous "Add and Read" format. In this chapter, we describe step-by-step protocols to create Lumit immunoassays for the detection of (1) secreted cytokines from cells, (2) phosphorylation levels of a specific signaling pathway node protein, and (3) a biochemical protein-protein interaction between a viral surface protein and its human receptor.

Identifiants

pubmed: 36795369
doi: 10.1007/978-1-0716-2903-1_15
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-224

Informations de copyright

© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Miyai K (1991) Classification of immunoassay. In: Price CP, Newman DJ (eds) Principles and practice of immunoassay. Palgrave Macmillan, London, pp 246–264
doi: 10.1007/978-1-349-11234-0_9
Dixon AS, Schwinn MK, Hall MP, Zimmerman K, Otto P, Lubben TH, Butler BL, Binkowski BF, Machleidt T, Kirkland TA, Wood MG, Eggers CT, Encell LP, Wood KV (2016) NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem Biol 11:400–408
doi: 10.1021/acschembio.5b00753 pubmed: 26569370
Hall MP, Unch J, Binkowski BF, Valley MP, Butler BL, Wood MG, Otto P, Zimmerman K, Vidugiris G, Machleidt T, Robers MB, Benink HA, Eggers CT, Slater MR, Meisenheimer PL, Klaubert DH, Fan F, Encell LP, Wood KV (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7:1848–1857
doi: 10.1021/cb3002478 pubmed: 22894855 pmcid: 3501149
Bodle CR, Hayes MP, O’Brien JB, Roman DL (2017) Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells. Anal Biochem 522:10–17
doi: 10.1016/j.ab.2017.01.013 pubmed: 28115169 pmcid: 5330260
Duellman SJ, Machleidt T, Cali JJ, Vidugiriene J (2017) Cell-based, bioluminescent assay for monitoring the interaction between PCSK9 and the LDL receptor. J Lipid Res 58:1722–1729
doi: 10.1194/jlr.D074658 pubmed: 28611099 pmcid: 5538273
Norisada J, Fujimura K, Amaya F, Kohno H, Hirata Y, Oh-hashi K (2018) Application of NanoBiT for monitoring dimerization of the Null Hong Kong variant of α-1-antitrypsin, NHK, in living cells. Mol Biotechnol 60:539–549
doi: 10.1007/s12033-018-0092-5 pubmed: 29876740
Hwang B, Engel L, Goueli SA, Zegzouti H (2020) A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation. Commun Biol 3:8
doi: 10.1038/s42003-019-0723-9 pubmed: 31909200
Nath N, Flemming R, Godat B, Urh M (2017) Development of NanoLuc bridging immunoassay for detection of anti-drug antibodies. J Immunol Methods 450:17–26
doi: 10.1016/j.jim.2017.07.006 pubmed: 28733215
Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta Mol Cell Res 1843:2563–2582
doi: 10.1016/j.bbamcr.2014.05.014
Lumit immunoassay cellular systems technical manual. https://www.promega.com/Resources/Protocols/Technical%20Manuals/500/lumit-immunoassay-cellular-systems-protocol/ . Accessed 8 Jan 2021

Auteurs

Byounghoon Brian Hwang (B)

R&D Department, Promega Corporation, Madison, WI, USA.
Abbvie, North Chicago, IL, USA.

Juliano Alves (J)

R&D Department, Promega Corporation, Madison, WI, USA.

Dan Lazar (D)

R&D Department, Promega Corporation, Madison, WI, USA.

Nidhi Nath (N)

R&D Department, Promega Corporation, Madison, WI, USA.
Bio-Techne, Minneapolis, MN, USA.

Laurie Engel (L)

R&D Department, Promega Corporation, Madison, WI, USA.

Martha O'Brien (M)

R&D Department, Promega Corporation, Madison, WI, USA.

Kevin Hsiao (K)

R&D Department, Promega Corporation, Madison, WI, USA.

Kevin Kupcho (K)

R&D Department, Promega Corporation, Madison, WI, USA.

Becky Godat (B)

R&D Department, Promega Corporation, Madison, WI, USA.

Rod Flemming (R)

R&D Department, Promega Corporation, Madison, WI, USA.

Said Goueli (S)

R&D Department, Promega Corporation, Madison, WI, USA.

Hicham Zegzouti (H)

R&D Department, Promega Corporation, Madison, WI, USA. hicham.zegzouti@promega.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH